DD139842A5 - Verfahren zur herstellung quaternaerer ammoniumsalze von phenylpropylaminen und phenylbutylaminen - Google Patents

Verfahren zur herstellung quaternaerer ammoniumsalze von phenylpropylaminen und phenylbutylaminen Download PDF

Info

Publication number
DD139842A5
DD139842A5 DD78209920A DD20992078A DD139842A5 DD 139842 A5 DD139842 A5 DD 139842A5 DD 78209920 A DD78209920 A DD 78209920A DD 20992078 A DD20992078 A DD 20992078A DD 139842 A5 DD139842 A5 DD 139842A5
Authority
DD
German Democratic Republic
Prior art keywords
methyl
bromide
preparation
item
reacting
Prior art date
Application number
DD78209920A
Other languages
German (de)
English (en)
Inventor
Bryan B Molloy
Mitchell I Steinberg
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DD139842A5 publication Critical patent/DD139842A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/037—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements with quaternary ring nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/62—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DD78209920A 1977-12-19 1978-12-19 Verfahren zur herstellung quaternaerer ammoniumsalze von phenylpropylaminen und phenylbutylaminen DD139842A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86178977A 1977-12-19 1977-12-19

Publications (1)

Publication Number Publication Date
DD139842A5 true DD139842A5 (de) 1980-01-23

Family

ID=25336767

Family Applications (1)

Application Number Title Priority Date Filing Date
DD78209920A DD139842A5 (de) 1977-12-19 1978-12-19 Verfahren zur herstellung quaternaerer ammoniumsalze von phenylpropylaminen und phenylbutylaminen

Country Status (28)

Country Link
EP (1) EP0002604B1 (ko)
JP (1) JPS5495520A (ko)
AR (1) AR222813A1 (ko)
AT (1) AT363065B (ko)
AU (1) AU524727B2 (ko)
BE (1) BE872832A (ko)
CA (1) CA1093072A (ko)
CH (1) CH640506A5 (ko)
CS (1) CS857778A2 (ko)
DD (1) DD139842A5 (ko)
DE (1) DE2862243D1 (ko)
DK (1) DK150475C (ko)
EG (1) EG14601A (ko)
ES (1) ES476152A1 (ko)
FI (1) FI65425C (ko)
FR (1) FR2411824A1 (ko)
GB (1) GB2011388B (ko)
HU (1) HU178220B (ko)
IE (1) IE47693B1 (ko)
IL (1) IL56212A (ko)
LU (1) LU80670A1 (ko)
NZ (1) NZ189162A (ko)
PH (1) PH14394A (ko)
PT (1) PT68907A (ko)
RO (1) RO76881A2 (ko)
SU (1) SU745360A3 (ko)
YU (1) YU297578A (ko)
ZA (1) ZA787111B (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4336269A (en) 1979-12-10 1982-06-22 Eli Lilly And Company Para-nitrophenylalkylamines
DE2952382A1 (de) * 1979-12-24 1981-07-16 Basf Ag, 6700 Ludwigshafen Phenylpropylammoniumsalze, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel
DE3263407D1 (en) * 1981-08-29 1985-06-05 Basf Ag Fungicides containing phenylpropylammonium salt, and process for combating fungi
DE3421810A1 (de) * 1984-06-12 1985-12-12 Basf Ag, 6700 Ludwigshafen Phenylalkylamine - bioregulatoren
JPS61140547A (ja) * 1984-12-13 1986-06-27 Seitai Kagaku Kenkyusho:Kk フェネチルアミン誘導体および診断・治療剤
JPH02268142A (ja) * 1989-04-10 1990-11-01 Toubishi Yakuhin Kogyo Kk 筋弛緩作用を有する新規化合物及びその製造方法
WO2001008685A1 (en) * 1999-07-30 2001-02-08 Vertex Pharmaceuticals Incorporated Acyclic and cyclic amine derivatives
TWI356054B (en) * 2004-03-31 2012-01-11 Activus Pharma Co Ltd Quaternary ammonium compound, producing method the

Also Published As

Publication number Publication date
ZA787111B (en) 1980-08-27
IE47693B1 (en) 1984-05-30
RO76881A2 (ro) 1981-08-30
DK150475C (da) 1987-10-26
GB2011388B (en) 1982-04-28
ES476152A1 (es) 1980-05-16
CA1093072A (en) 1981-01-06
DE2862243D1 (en) 1983-06-09
CS857778A2 (en) 1985-07-16
PH14394A (en) 1981-06-25
AR222813A1 (es) 1981-06-30
DK567778A (da) 1979-07-31
YU297578A (en) 1982-10-31
BE872832A (fr) 1979-06-18
PT68907A (en) 1979-01-01
HU178220B (en) 1982-03-28
EP0002604A1 (en) 1979-06-27
GB2011388A (en) 1979-07-11
IL56212A0 (en) 1979-03-12
JPS5495520A (en) 1979-07-28
DK150475B (da) 1987-03-09
FI783845A (fi) 1979-06-20
FI65425C (fi) 1984-05-10
IL56212A (en) 1982-08-31
NZ189162A (en) 1980-10-24
EP0002604B1 (en) 1983-05-04
FI65425B (fi) 1984-01-31
FR2411824B1 (ko) 1985-03-29
JPS6214538B2 (ko) 1987-04-02
SU745360A3 (ru) 1980-06-30
EG14601A (en) 1984-09-30
ATA904378A (de) 1980-12-15
AU524727B2 (en) 1982-09-30
CH640506A5 (fr) 1984-01-13
LU80670A1 (fr) 1979-04-13
IE782489L (en) 1979-06-19
AU4255478A (en) 1979-06-28
AT363065B (de) 1981-07-10
FR2411824A1 (fr) 1979-07-13

Similar Documents

Publication Publication Date Title
DE3751006T2 (de) Psychostimulierendes mittel.
DE2901032C2 (de) Substituierte Morpholin-Derivate und deren Verwendung
DE69704679T2 (de) 4-phenylpiperidin-derivate
DE2907217C2 (de) 3-Phenyl-3-phenoxypropylamin-Derivate und deren Salze, deren Herstellung und diese enthaltende Arzneimittel
DE2500110A1 (de) 3-aryloxy-3-phenylpropylamine und verfahren zu ihrer herstellung
DE1643262C3 (de) i-Phenoxy^-hydroxy-S-alklyaminopropane, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DD144763A5 (de) Verfahren zur herstellung von phenethanolaminen
DE69116237T2 (de) Derivate von Hexahydroazepine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DD155065A5 (de) Verfahren zur herstellung von phenylazacycloalkanen
DE3586411T2 (de) Dopamin-antagoniste.
DD139842A5 (de) Verfahren zur herstellung quaternaerer ammoniumsalze von phenylpropylaminen und phenylbutylaminen
DE2362754C2 (de) Cyclopropylalkylaminoreste enthaltende Oxazolinverbindungen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3320394A1 (de) Optisch aktive n-arylierte oxazolidinon-(2)-derivate, deren verwendung als spezifische und reversible inhibitoren von monoaminooxydase des b-typs sowie verfahren zu deren herstellung
DE1915230C3 (de) Hydroxyphenylalkylaminderivate, Verfahren zu deren Herstellung und Arzneimittel auf deren Basis
DE2507429C2 (de) Aminosäureester, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2835536A1 (de) Verfahren zur erzielung eines antioestrogenen effekts bei warmbluetern, hierfuer geeignete zusammensetzungen und verbindungen sowie verfahren zur herstellung dieser verbindungen
DE2522218C3 (de) Zusammensetzung für die Human- oder Veterinärmedizin, Methylaminderivate und Verfahren zu deren Herstellung
EP0778274A1 (de) Amidinohydrazone vom Benzo(b)furan abgeleiteter Ketone, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE69003031T2 (de) 2-Amino-1,2,3,4-Tetrahydronaphthalin-Derivate mit kardiovaskularer Wirkung, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten.
DE1643198A1 (de) Diarylcyclopropanderivate und Verfahren zu ihrer Herstellung
DE2166662C3 (de) Dibenzothiazepinderivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
EP0388739A1 (de) Tetrahydronaphtalinderivate
DE2738131A1 (de) Aminoketone, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE2106620C3 (de) ureidobenzylalkohole und Verfahren zu ihrer Herstellung
EP0107208B1 (de) Neue 1,1,2-Triphenyl-but-1-en-Derivate, sowie Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel